Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CoronaVirus Disease-2019 (COVID-19)”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05437289
What this trial is testing

Evaluate the Safety and Tolerability of AZD7442 in Healthy Chinese Adults

Who this might be right for
Coronavirus Disease 2019 (COVID-19)Healthy Volunteer
AstraZeneca 61
Post-approval studies (Phase 4)Study completedNCT05406908
What this trial is testing

Intradermal Tozinameran for Patients With Immune-mediated Dermatologic Diseases

Who this might be right for
Bullous DermatosesPsoriasisCOVID-19 Vaccines
Mahidol University 109
Early research (Phase 1)Study completedNCT04516564
What this trial is testing

AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
Akesobio Australia Pty Ltd 29
Not applicableStudy completedNCT04359212
What this trial is testing

Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19

Who this might be right for
COVID-19 DiseaseThromboembolism, Venous
Quovadis Associazione 90
Testing effectiveness (Phase 2)Study completedNCT04678830
What this trial is testing

Double Blind, Placebo Controlled Study of Safety and Efficacy of Leronlimab in Patients With "Long" COVID-19

Who this might be right for
Coronavirus Disease 2019
CytoDyn, Inc. 56
Testing effectiveness (Phase 2)Study completedNCT04426695
What this trial is testing

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19

Who this might be right for
COVID-19
Regeneron Pharmaceuticals 2,252
Testing effectiveness (Phase 2)Study completedNCT04409509
What this trial is testing

Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
CSL Behring 124
Not applicableUnknownNCT04443712
What this trial is testing

Screening for Patients Admitted to Ain-Shams University Hospitals for SARS-COV-2 (COVID19)

Who this might be right for
Coronavirus Disease 2019 (COVID19)
Samia Girgis 1,900
Not applicableUnknownNCT04487665
What this trial is testing

Oral Manifestations of Coronavirus Disease 2019(COVID-19) :a Multicentre Study

Who this might be right for
Covid19
Cairo University 50
Not applicableStudy completedNCT06170320
What this trial is testing

STREngthening COronavirus Disease 2019 (COVID-19) Surveillance in Africa

Who this might be right for
COVID-19SARS CoV 2 InfectionCOVID-19 Pandemic
Institut de Recherche pour le Developpement 7,000
Not applicableStudy completedNCT05120869
What this trial is testing

Healthcare Provider Human Papillomavirus Education and Professional Skills Intervention

Who this might be right for
Health Personnel AttitudeHealth Knowledge, Attitudes, Practice
University of Texas, El Paso 161
Testing effectiveness (Phase 2)Ended earlyNCT05451654
What this trial is testing

NanoMn®_COVID-19 A Prospective, Multicenter, Randomized, Placebo-controlled, Parallel-group, Double-blind Trial to Evaluate the Clinical Efficacy of NanoManganese® on Top of Standard of Care, in Adult Patients With Moderate to Severe Coronavirus Disease 2019 (COVID-19)

Who this might be right for
COVID-19 Pandemic
Medesis Pharma SA 7
Testing effectiveness (Phase 2)Study completedNCT04359654
What this trial is testing

Nebulised Dornase Alfa for Treatment of COVID-19 (Coronavirus Disease 2019)

Who this might be right for
COVID-19 (Coronavirus Disease 2019)Hypoxia
University College, London 41
Post-approval studies (Phase 4)Ended earlyNCT04351191
What this trial is testing

PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds

Who this might be right for
Sars-CoV2Symptomatic ConditionCovid-19
Government of Punjab, Specialized Healthcare and Medical Education Department 137
Not applicableStudy completedNCT04760561
What this trial is testing

Awake Prone Positioning for Non-intubated COVID-19 Patients

Who this might be right for
Prone PositionCoronavirus Disease 2019Oxygenation
Damanhour University 82
Not applicableStudy completedNCT04424017
What this trial is testing

Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers

Who this might be right for
COVIDCorona Virus Infection
Egyptian Center for Research and Regenerative Medicine 1,546
Early research (Phase 1)WithdrawnNCT04425733
What this trial is testing

Frespaciguat (MK-5475) in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009)

Who this might be right for
Coronavirus Disease 2019 (COVID-19)PneumoniaHypoxemia
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Study completedNCT04317040
What this trial is testing

Efprezimod Alfa (CD24Fc, MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007)

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 234
Post-approval studies (Phase 4)UnknownNCT04308317
What this trial is testing

Tetrandrine Tablets Used in the Treatment of COVID-19

Who this might be right for
Corona Virus Disease 2019,COVID-19
Henan Provincial People's Hospital 60
Not applicableWithdrawnNCT04383899
What this trial is testing

Role of Ibuprofen and Other Medicines on Severity of Coronavirus Disease 2019

Who this might be right for
Coronavirus Infection
University Hospital, Bordeaux
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation